Medication Management Made Sympl
Symplmed Pharmaceuticals is a new kind of pharmaceutical company. Like our peers, we offer life‑saving and innovative medications—ours and our partners. But only Symplmed is revolutionizing the entire drug delivery process through our patented DyrctAxess™ technology platform by:
- Eliminating inefficiencies associated with drug prescribing, payment and fulfillment
- Empowering patients, physicians and manufacturers with the information they need to improve compliance and help achieve optimal care
Innovative Products for Hypertension
Our initial product focus is hypertension and features Symplmed’s proprietary ACE inhibitor ACEON® (perindopril erbumine). Our growing pipeline includes Prestalia®, a single-pill, fixed‑dose combination (FDC) of perindopril arginine and amlodipine besylate currently under review by the FDA, and three additional perindopril FDCs being prepared for Phase III programs in the first half of 2015.
Learn how you can eliminate the hassles of paperwork and improve patient care with bpCareConnect. It’s available for your desktop, tablet or mobile phone and can be set up in minutes.
Are you living with hypertension? Interested in a better, easier and likely less expensive way to receive your medications and manage your treatment? With your physician, enroll in our hypertension management program, bpCareConnect, today!
July 18, 2014 Symplmed announced today that it has acquired U.S. rights to ACEON®
June 17, 2014 FDA Accepts New Drug Application for Symplmed's Prestalia® for the Treatment of Hypertension